Publications
5532 Results
- Journal / Conference
- ASCO 12:330(#1099)
- Year
- 1993
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8812
The role of alpha interferon (rINFa2a) maintenance in patients with limited stage SCLC responding to con-current chemoradiation: A Southwest Oncology Group study.
- Journal / Conference
- ASCO 12:253(#799)
- Year
- 1993
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8824
A phase II trial of continuous infusion recombinant interleukin-2 (rIL-2) in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.
- Journal / Conference
- ASCO 12:198(#583)
- Year
- 1993
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8905
Fluorouracil (5-FU) schedules and modulation in advanced colorectal cancer (CRC): A Southwest Oncology Group screening trial.
- Journal / Conference
- ASCO 12:394(#1349)
- Year
- 1993
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8921
The addition of tamoxifen (T) to dacarbazine (D) and cisplatin (C) in a Southwest Oncology Group phase II trial (8921) in metastatic malignant melanoma (MMM) stage IV.
- Journal / Conference
- ASCO 34:203(#1214)
- Year
- 1993
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8956
Evaluation of cisplatin + 5 fluorouracil infusion for advanced/metastatic transitional cell carcinoma of the bladder. (AMTCCB). A Southwest Oncology Group study.
- Journal / Conference
- ASCO 12:201(#596)
- Year
- 1993
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9006, SWOG-9118
Modulation of intratumoral (IT) 5FU pharmacokinetics (PK) by leucovorin (LV) and methotrexate (M) documented by 19F-magnetic resonance spectroscopy (MRS) initial results of Southwest Oncology Group studies 9006 and 9118.
- Journal / Conference
- ASCO 12:200(#592)
- Year
- 1993
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9135
A phase II trial of taxol and granulocyte colony stimulating factor (G-CSF) in patients with adenocarcinoma of the pancreas.
- Journal / Conference
- ASCO 12:243(#760)
- Year
- 1993
Effects of prior hormone therapy on response and survival in Southwest OncologyGroup phase II chemotherapy trials.
- Journal / Conference
- ASCO 12:176(#502)
- Year
- 1993
Assessment of response to new agents for primary CNS malignancies (CNS).
- Journal / Conference
- JCO 11:161-165
- Year
- 1993
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8325